# Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

> **NCT06972875** · PHASE2 · RECRUITING · sponsor: **University of Vermont** · enrollment: 32 (estimated)

## Conditions studied

- Prostate CA
- Androgen Deprivation Therapy

## Interventions

- **DRUG:** Fezolinetant

## Key facts

- **NCT ID:** NCT06972875
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-18
- **Primary completion:** 2027-01
- **Final completion:** 2027-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972875, "Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06972875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*